Logo image of USNA

USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis

USA - NYSE:USNA - US90328M1071 - Common Stock

30.35 USD
-0.49 (-1.59%)
Last: 9/19/2025, 10:18:56 AM
Fundamental Rating

6

Overall USNA gets a fundamental rating of 6 out of 10. We evaluated USNA against 36 industry peers in the Personal Care Products industry. USNA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. USNA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

USNA had positive earnings in the past year.
USNA had a positive operating cash flow in the past year.
USNA had positive earnings in each of the past 5 years.
In the past 5 years USNA always reported a positive cash flow from operatings.
USNA Yearly Net Income VS EBIT VS OCF VS FCFUSNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

USNA has a better Return On Assets (4.64%) than 61.11% of its industry peers.
USNA's Return On Equity of 6.42% is fine compared to the rest of the industry. USNA outperforms 69.44% of its industry peers.
USNA has a Return On Invested Capital of 5.38%. This is comparable to the rest of the industry: USNA outperforms 58.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for USNA is below the industry average of 12.97%.
The last Return On Invested Capital (5.38%) for USNA is well below the 3 year average (10.32%), which needs to be investigated, but indicates that USNA had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.64%
ROE 6.42%
ROIC 5.38%
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
USNA Yearly ROA, ROE, ROICUSNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of USNA (3.79%) is better than 63.89% of its industry peers.
In the last couple of years the Profit Margin of USNA has declined.
USNA has a better Operating Margin (6.25%) than 61.11% of its industry peers.
In the last couple of years the Operating Margin of USNA has declined.
The Gross Margin of USNA (79.93%) is better than 94.44% of its industry peers.
USNA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.25%
PM (TTM) 3.79%
GM 79.93%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
USNA Yearly Profit, Operating, Gross MarginsUSNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

8

2. Health

2.1 Basic Checks

USNA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, USNA has less shares outstanding
USNA has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, USNA has a worse debt to assets ratio.
USNA Yearly Shares OutstandingUSNA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
USNA Yearly Total Debt VS Total AssetsUSNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 4.27 indicates that USNA is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.27, USNA is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
USNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.27
ROIC/WACC0.63
WACC8.53%
USNA Yearly LT Debt VS Equity VS FCFUSNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 2.15 indicates that USNA has no problem at all paying its short term obligations.
USNA has a Current ratio of 2.15. This is comparable to the rest of the industry: USNA outperforms 58.33% of its industry peers.
A Quick Ratio of 1.47 indicates that USNA should not have too much problems paying its short term obligations.
USNA has a Quick ratio of 1.47. This is in the better half of the industry: USNA outperforms 63.89% of its industry peers.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.47
USNA Yearly Current Assets VS Current LiabilitesUSNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

USNA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.64%.
USNA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.07% yearly.
Looking at the last year, USNA shows a small growth in Revenue. The Revenue has grown by 2.75% in the last year.
Measured over the past years, USNA shows a decrease in Revenue. The Revenue has been decreasing by -4.23% on average per year.
EPS 1Y (TTM)-6.64%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%37.04%
Revenue 1Y (TTM)2.75%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%10.87%

3.2 Future

The Earnings Per Share is expected to grow by 15.49% on average over the next years. This is quite good.
Based on estimates for the next years, USNA will show a quite strong growth in Revenue. The Revenue will grow by 10.12% on average per year.
EPS Next Y2.78%
EPS Next 2Y15.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.33%
Revenue Next 2Y10.12%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
USNA Yearly Revenue VS EstimatesUSNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
USNA Yearly EPS VS EstimatesUSNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.37, the valuation of USNA can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 88.89% of the companies listed in the same industry.
USNA is valuated cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 8.75, which indicates a very decent valuation of USNA.
Based on the Price/Forward Earnings ratio, USNA is valued cheaper than 86.11% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of USNA to the average of the S&P500 Index (22.88), we can say USNA is valued rather cheaply.
Industry RankSector Rank
PE 11.37
Fwd PE 8.75
USNA Price Earnings VS Forward Price EarningsUSNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, USNA is valued cheaper than 94.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.51
USNA Per share dataUSNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
USNA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as USNA's earnings are expected to grow with 15.49% in the coming years.
PEG (NY)4.08
PEG (5Y)N/A
EPS Next 2Y15.49%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for USNA!.
Industry RankSector Rank
Dividend Yield N/A

USANA HEALTH SCIENCES INC

NYSE:USNA (9/19/2025, 10:18:56 AM)

30.35

-0.49 (-1.59%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)07-22 2025-07-22/amc
Earnings (Next)10-20 2025-10-20/amc
Inst Owners58.05%
Inst Owner Change2.85%
Ins Owners0.61%
Ins Owner Change-0.04%
Market Cap554.49M
Analysts43.33
Price Target62.22 (105.01%)
Short Float %6.77%
Short Ratio5.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.3%
Min EPS beat(2)2.24%
Max EPS beat(2)34.35%
EPS beat(4)4
Avg EPS beat(4)19.49%
Min EPS beat(4)2.24%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)17.25%
EPS beat(12)9
Avg EPS beat(12)21.2%
EPS beat(16)10
Avg EPS beat(16)13.82%
Revenue beat(2)2
Avg Revenue beat(2)1.7%
Min Revenue beat(2)0.66%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.23%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.39%
Revenue beat(12)7
Avg Revenue beat(12)-0.44%
Revenue beat(16)9
Avg Revenue beat(16)-0.74%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-27.69%
EPS NY rev (1m)0.38%
EPS NY rev (3m)0.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE 11.37
Fwd PE 8.75
P/S 0.62
P/FCF N/A
P/OCF 8.8
P/B 1.04
P/tB 2.27
EV/EBITDA 4.51
EPS(TTM)2.67
EY8.8%
EPS(NY)3.47
Fwd EY11.43%
FCF(TTM)-8.34
FCFYN/A
OCF(TTM)3.45
OCFY11.37%
SpS49.22
BVpS29.07
TBVpS13.36
PEG (NY)4.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.64%
ROE 6.42%
ROCE 9.17%
ROIC 5.38%
ROICexc 7.14%
ROICexgc 18.89%
OM 6.25%
PM (TTM) 3.79%
GM 79.93%
FCFM N/A
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
ROICexc(3y)25.77%
ROICexc(5y)39.61%
ROICexgc(3y)41.63%
ROICexgc(5y)58.84%
ROCE(3y)17.59%
ROCE(5y)26.19%
ROICexcg growth 3Y-27.3%
ROICexcg growth 5Y-19.15%
ROICexc growth 3Y-45.52%
ROICexc growth 5Y-31.11%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
F-Score5
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 613.46%
Cap/Sales 23.95%
Interest Coverage 84.38
Cash Conversion 69.02%
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 1.47
Altman-Z 4.27
F-Score5
WACC8.53%
ROIC/WACC0.63
Cap/Depr(3y)385.75%
Cap/Depr(5y)273.18%
Cap/Sales(3y)9.41%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.64%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%37.04%
EPS Next Y2.78%
EPS Next 2Y15.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.75%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%10.87%
Revenue Next Year12.33%
Revenue Next 2Y10.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.36%
EBIT growth 3Y-26.96%
EBIT growth 5Y-14.62%
EBIT Next Year52.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-291.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.5%
OCF growth 3Y-20.46%
OCF growth 5Y-13.6%